Cardiorenal Actions of New Designer Natriuretic Peptide CD-NP in Experimental Heart Failure

被引：0
|
作者：
Lisy, Ondrej J. [1 ]
Chen, Horng H. [1 ]
Burnett, John C., Jr. [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2009年 / 53卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A149 / A149
页数：1
相关论文
共 50 条
  • [21] A phase I clinical trial on a novel chimeric natriuretic peptide, CD-NP
    Lee, Candace Y. W.
    Chen, Horng H.
    Lisy, Ondrej
    Sandberg, Sharon M.
    Heublein, Denise M.
    Burnett, John C., Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A324 - A324
  • [22] Potent cardiac unloading actions of a new synthetic natriuretic peptide (BD-NP) in experimental severe congestive heart failure
    Boerrigter, G
    Costello, LC
    Lisy, O
    Cataliotti, A
    Tsuruda, T
    Harty, GJ
    Burnett, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 231A - 231A
  • [23] HORMONAL EFFECTS OF A NOVEL DESIGNER NATRIURETIC PEPTIDE, CU-NP, IN A CANINE MODEL OF EXPERIMENTAL HEART FAILURE.
    Lee, C. Y.
    Chen, H. H.
    Boerrigter, G.
    Harty, G. J.
    Heublein, D. M.
    Burnett, J. C., Jr.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S12 - S13
  • [24] Initial observations of intravenous CD-NP, chimeric natriuretic peptide, on renal function in chronic heart falure patients
    Lieu, H. D.
    Goldsmith, S. R.
    Neutel, J. M.
    Massie, B. M.
    Mann, D. L.
    Komajda, M.
    Young, J. B.
    Hodge, J.
    Chen, H. H.
    Burnett, J. C.
    EUROPEAN HEART JOURNAL, 2009, 30 : 425 - 425
  • [25] Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure
    Lisy, O
    Lainchbury, JG
    Leskinen, H
    Burnett, JC
    HYPERTENSION, 2001, 37 (04) : 1089 - 1094
  • [26] Cardiorenal enhancing and aldosterone suppressing actions of a novel designer natriuretic peptide in experimental hypertension with ventricular pressure overload
    Mckie, P.
    Cataliotti, A.
    Boerrigter, G.
    Sangaralingham, J.
    Ichiki, T.
    Chen, H.
    Burnett, J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 321 - 321
  • [27] A Dual Inhibitor of Neprilysin and Ligand of the Natriuretic Peptide Receptor C Augments the Endogenous Natriuretic Peptide System and Has Favorable Cardiorenal Actions in Experimental Heart Failure
    Boerrigter, Guido
    Costello-Boerrigter, Lisa C.
    Lapp, Harald
    Beck, Hartmut
    Stasch, Johannes-Peter
    Burnett, John C., Jr.
    CIRCULATION, 2009, 120 (18) : S734 - S734
  • [28] A PHASE II, DOSE-RANGING STUDY WITH CD-NP, A CHIMERIC NATRIURETIC PEPTIDE, IN ACUTE DECOMPENSATED HEART FAILURE PATIENTS WITH RENAL COMPROMISE
    Lieu, Hsiao Dee
    Young, James
    Elkayam, Uri
    Katz, Amos
    Darius, Harald
    Goldstein, Sidney
    Massie, Barry
    Costello-Boerrigter, Lisa
    Burnett, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E2029 - E2029
  • [29] Therapeutic actions of a new natriuretic and vasoactive peptide DNP in experimental severe congestive heart failure
    Lisy, O
    Lainchbury, JG
    Burnett, JC
    CIRCULATION, 1999, 100 (18) : 636 - 636
  • [30] Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: Insights from experimental heart failure
    Chen H.H.
    Cataliotti A.
    Burnett Jr. J.C.
    Current Hypertension Reports, 2001, 3 (Suppl 2) : s15 - s21
12345